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EDITORIAL SUMMARY: EmRiboSeq determines the precise location of embedded ribonucleotides in 
the S. cerevisiae genome, tracking DNA polymerase activity in vivo. An adaptation of this protocol, 
EndoSeq, also allows the genome-wide mapping of other non-canonical bases.  
TWEET: Genome-wide mapping of embedded ribonucleotides using emRiboSeq 
KEYWORDS 
Embedded ribonucleotide, ribonucleotide misincorporation, genome-wide mapping, RNase H2, 
Ribonuclease H2, non-canonical nucleotide, base modification, endonuclease, library preparation, 
next generation sequencing, high-throughput sequencing, DNA replication, DNA polymerase 
ABSTRACT 
Ribonucleotides are the most common non-canonical nucleotides incorporated into the genome of 
replicating cells. They are efficiently removed by ribonucleotide excision repair initiated by 
Ribonuclease (RNase) H2 cleavage. In the absence of RNase H2, such embedded ribonucleotides can 
be used to track DNA polymerase activity in vivo. To determine their precise location in 
Saccharomyces cerevisiae we developed embedded Ribonucleotide Sequencing (emRiboSeq), which 
uses recombinant RNase H2 to selectively create ligatable 3’-hydroxyl groups, in contrast to 
alternative methods that utilize alkaline hydrolysis. EmRiboSeq allows reproducible, strand-specific 
and potentially quantitative detection of embedded ribonucleotides at single-nucleotide resolution. 
This protocol can be adapted for the genome-wide mapping of other non-canonical bases by 
replacing RNase H2 with specific nicking endonucleases, a method we term Endonuclease 
Sequencing (EndoSeq). With the protocol taking <5 days to complete, these methods allow the in 
vivo study of DNA replication and repair, including the identification of replication origins and 
termination regions. 
INTRODUCTION 
Ribonucleotides are frequently incorporated into DNA by DNA polymerases1-9 a subject of increasing 
interest discussed in a number of recent reviews10-15. Under normal conditions the cell can use their 
transient presence to its advantage: ribonucleotide incorporation by polymerase mu (Pol-µ) is 
thought to be beneficial for double-strand break repair by nonhomologous end joining7,16, whereas 
ribonucleotide incorporation on the leading strand by Pol-ε promotes mismatch repair17,18. However, 
failure to remove embedded ribonucleotides, i.e. absence of RNase H2, results in genome 
instability6,8,19-25. This may be linked to heritable autoinflammatory disorders such as Aicardi–
Goutières syndrome21,25-27 and Systemic lupus erythematosus21, and could have relevance for the 
neurodegenerative disorder Ataxia with Oculomotor Apraxia 128,29. To map the genome-wide 
distribution of these embedded ribonucleotides we developed a next generation sequencing (NGS) 
method, emRiboSeq30, which relies on cleavage of the phosphodiester bond directly 5’ of a DNA-
embedded ribonucleotide with recombinant RNase H2. In the cell, cleavage by RNase H2 initiates 
the removal of misincorporated ribonucleotides, a process termed ribonucleotide excision repair 
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(RER)31. Therefore, the use of RNase H2 deficient cells is essential to allow mapping of 
ribonucleotides. We successfully used this approach to establish that ribonucleotide incorporation 
patterns in the Saccharomyces cerevisiae genome are non-random, and to map the contribution of 
the replicative DNA polymerases30 (Pol-ε, Pol-δ and Pol-α) using point mutations that alter their 
propensity to incorporate ribonucleotides6,18,32. In addition, this accurately identified origins of 
replication and termination regions at high resolution. In parallel three other groups developed 
different methods to map embedded ribonucleotides, yielding similar findings33-36 (see also further 
comparison below). 
Overview of emRiboSeq 
Here we describe the details of the emRiboSeq protocol, which could potentially be applied to any 
organism, although we emphasise its application to S. cerevisiae with its relatively compact genome. 
In brief, the protocol (Fig. 1) includes isolation and sonication of genomic DNA, followed by end 
repair, deoxyadenosine-tailing and ligation of fragments to adapters with a deoxythymidine 
overhang on one end and a non-ligatable 2’,3’-dideoxycytidine on the other. In order to minimise 
the contribution of nicks or double strand breaks to background, pre-existing 3’-hydroxyl (3’-OH) 
groups are blocked using terminal transferase and 2’,3’-dideoxyadenosine-triphosphate (ddATP). 
The library of ligated fragments is then treated with RNase H2 (for emRiboSeq or another 
appropriate endonuclease for EndoSeq), generating 3’-OH and 5’-phosphate (5’-P) groups. 
Phosphates are removed to increase subsequent adapter ligation efficiency, followed by 
denaturation and annealing of single stranded fragments to double stranded adapters with a 3’ 
random hexamer overhang. This allows ligation of the adapter to only those fragments with free 3’-
OH ends. A conjugated biotin molecule in the random hexamer containing strand of the second 
adapter allows ligated fragments to be captured. Elution of the full length non-biotinylated strand is 
followed by second strand synthesis to produce a library that requires only size selection prior to 
sequencing.  
Applications of the method 
Genome-wide mapping of embedded ribonucleotides can offer insights into DNA replication and 
repair processes, as it allows in vivo tracking of DNA polymerase activities30,33-35. In addition to the 
potential for identifying replication origins and termination regions, emRiboSeq will facilitate the 
study of the causes and consequences of ribonucleotide misincorporation. Furthermore, to examine 
the distribution of other non-canonical nucleotides only a single step in the emRiboSeq protocol 
needs to be changed. In EndoSeq, appropriate nicking endonucleases that selectively cleave and 
generate 3’-OH ends can be used in place of RNase H2. This could be applied to lesions such as 
apurinic/apyrimidinic (AP) sites (e.g. using AP endonuclease 1, APE1), embedded deoxyinosines (e.g. 
using E. coli Endo V) or UV-induced damage such as cyclobutane pyrimidine dimers (CPDs, e.g. using 
UV damage endonuclease, UVDE). In other cases, multiple enzymes may be required to generate the 
required 3’-OH ends, such as the detection of embedded deoxyuracil by treatment with uracil-DNA 
glycosylase (UDG) to generate AP sites, which could then be cleaved by AP lyase enzymes (e.g.APE1 
or Endo IV). Endonucleases that generate double strand breaks can also be used, although in this 
case strand-specific information is lost. We established proof of principle of the EndoSeq approach 
using sequence-specific endonucleases30. Together, emRiboSeq and EndoSeq add important tools to 
the molecular biology toolbox used to study DNA replication, damage and repair. 
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Comparison with other methods 
Three other methods that allow embedded ribonucleotides to be mapped were developed 
independently33-35, highlighting the current interest in studying ribonucleotide incorporation and in 
vivo polymerase contributions. A useful review and comparison of all four methods, emRiboSeq30, 
HydEn-seq33, ribose-seq35,36 and Pu-seq34, was made by Jinks-Robertson & Klein37. Whereas 
emRiboSeq uses enzymatic hydrolysis of embedded ribonucleotides (generating 5’-P and 3’-OH 
ends), the other three methods make use of alkaline hydrolysis of ribonucleotide-containing DNA 
(generating 5’-OH and 2’,3’-cyclic phosphates). The advantage of chemical hydrolysis is the simplicity 
of the procedure; a disadvantage is the fact that abasic sites are also prone to hydrolysis38, which 
may cause higher background. Post-hydrolysis, both emRiboSeq and ribose-seq capture the strand 
upstream of the nick, whereas HydEn-seq and Pu-seq capture the downstream fragment. The 
principle of specifically capturing these ends differs for each method. HydEn-seq phosphorylates the 
5’-OH ends and uses this to ligate on a first adapter; a second random hexamer-containing adapter is 
used for second strand synthesis, followed by PCR amplification. Pu-seq uses random priming to 
perform second strand synthesis in the presence of deoxyuridine (dU) tri-phosphate, generating 
blunt ends that allow adapter ligation. The dU-containing strand is then degraded and the original 
strand, which now contains adapters, amplified. Ribose-seq initially ligates a two-sided adapter to 
the 5’-end of fragments, followed by circular ligation using Arabidopsis thaliana tRNA ligase (AtRNL), 
an enzyme that specifically allows single stranded ligation to 2’,3’-cyclic phosphates. Subsequent 
degradation of linear DNA allows specific amplification of circular fragments. Each of the four 
methods is likely to introduce certain biases, which future in-depth side-by-side comparison will be 
useful to delineate. Notably, with the exception of emRiboSeq each of these library preparation 
methods uses PCR pre-amplification, itself a potential source of bias.   
Although these four methods achieve broadly the same outcome, the investigator may wish to 
consider the pros and cons of each before deciding which methodology to employ. The main 
strengths of emRiboSeq are that it is a robust, reproducible and validated technique, and the 
absence of pre-sequencing amplification means that no de-duplication is necessary during 
bioinformatics analysis, resulting in superior read depth. In addition, the lack of pre-amplification 
also gives it the potential to be used as a quantitative method, although the precision of quantitation 
will depend on the efficiency of all of the enzymatic steps in the library preparation (each should be 
performed to completion and under conditions that allow high specificity), as well as the quality of 
the starting material. 
Potential disadvantages of our protocol are its relative length and its dependence on enzymatic 
cleavage, which could introduce enzyme-specific bias. In our published work we successfully 
employed recombinant human RNase H2 purified in our own laboratory. More recently, we have 
also generated emRiboSeq libraries using a commercially available preparation of RNase HII (New 
England Biolabs) with preliminary analyses showing that these produce similar data, indicating that 
type 2 RNase H enzymes from other sources can be used. However, careful experimental design and 
interpretation when using nucleases is important, and potential site specific variation in activity or 
risk of low level contaminating nuclease activity in both commercial and lab generated enzymes 
should be kept in mind. Optimal conditions for emRiboseq are those under which all ribonucleotides 
are cleaved whilst minimising non-specific cleavage. While the use of alkaline hydrolysis in other 
methods may result in detection of sites additional to ribonucleotides (e.g. abasic residues), this will 
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also circumvent potential problems such as sequence-specific biases in cleavage or contaminating 
nucleases. 
Our method can be adapted to use endonucleases other than RNase H2 to study different non-
canonical nucleotides. The EndoSeq method can be compared to Excision-seq, an alternative 
method that makes use of enzymatic cleavage at modified bases to determine their genome-wide 
distribution39. However, this method requires the modifications under investigation to be present at 
a high enough frequency to generate sufficiently small fragments. This is not a limitation for 
EndoSeq, as fragment size is determined by initial sonication, although the presence of modifications 
at too high a frequency could be problematic as discussed below. 
 
Experimental Design 
Sequencing platform. This protocol was developed using the Ion Torrent™ NGS platform (Life 
Technologies), but can be adapted to other platforms by changing the adapter sequences, which in 
our case were designed for compatibility with the capture and sequencing primers used for Ion 
Torrent™. The optimum length of fragments within a NGS library also differs according to the 
platform used and consequently the size selection range (Step 75) would also require adjustment. 
When applying our method to organisms with a substantially larger genome than that of S. 
cerevisiae read depth may become an issue, in which case the use of a sequencing methodology that 
generates larger numbers of reads will need to be considered. 
EndoSeq: Use of alternative endonucleases. When substituting RNase H2 with alternative 
endonucleases to determine the genomic distribution of non-canonical nucleotides other than 
ribonucleotides there are several important considerations. The specificity of the endonuclease is 
crucial and where possible non-specific activity should be carefully avoided. It is therefore 
recommended that optimum conditions be established for Step 46. High frequency cleavage (i.e. >1 
cut every 400 basepairs, bp) is not desirable as fragments that are cleaved multiple times are likely 
to be lost during final size selection. In this case, partial digestion may be possible, but this is likely to 
introduce bias, with sites that are preferentially cleaved overrepresented. Cleavage frequency of a 
particular nicking endonuclease can be assessed by alkaline gel electrophoresis of enzyme-treated 
DNA, followed by densitometry8,30. Existing estimates of ribonucleotide incorporation rates by S. 
cerevisiae polymerases5,6,30 mean that multiple cleavage of sonicated fragments should be a rare 
event in the emRiboSeq protocol, although the occurrence of closely spaced ribonucleotides at 
specific positions cannot be ruled out. EmRiboSeq would not detect these with only the most 5’ site 
captured.  
Starting material. Isolation of genomic DNA (gDNA) is performed under conditions that minimise 
the generation of nicks. Where the endonuclease substrate is rapidly removed by endogenous 
processes it will be necessary to isolate gDNA from cells in which these processes are inactive, either 
through genetic (knock-out or knock-down) or chemical means (inhibitors). Although other, less 
efficient mechanisms exist for the removal of embedded ribonucleotides40-42, the use of RNase H2 
null S. cerevisiae in emRiboSeq was shown to be sufficient to allow mapping of ribonucleotides 
misincorporated by replicative DNA polymerases30. For similar experiments, the use of strains in 
which at least one of the genes encoding the RNase H2 subunits, RNH201, RNH202 or RNH203, is 
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deleted is therefore recommended. We have used both mid-log phase (A600 nm = 0.5) and stationary 
phase cultures (A600 nm = 5 to 6) with similar results. 
 
The emRiboSeq protocol was implemented in S. cerevisiae, which offers a number of advantages 
including ease of genetic engineering and a small, well defined genome. Additionally, RNase H2 
deficient yeast proliferates at a normal rate, unlike RNase H2 null mammalian cells, although 
absence of RNase H2 activity in budding yeast does cause mutation rate increase and genome 
instability6,19,24,42-45. 
If using gDNA from a source other than S. cerevisiae, Steps 1-15 should be replaced with an 
appropriate protocol for isolating gDNA in which cleavage at embedded ribonucleotides is avoided 
prior to Step 46. In our protocol this was ensured by performing RNase treatment under high salt 
conditions (Step 15). Because our protocol does not use pre-amplification a large quantity of starting 
material is crucial: we recommend starting with 18 µg of DNA, so that 5 µg can be used as input for 
end repair (Step 32), although we have been successful with input amounts as low as 1 µg. 
 
Controls. It is recommended that control experiments are performed when first carrying out this 
protocol, especially when using a new endonuclease. These include the preparation of an 
‘endonuclease negative’ library where endonuclease treatment (Step 46) is omitted. This should 
result in the absence of 3’-OH groups available for ligation to the second adapter (Steps 52-54) and, 
therefore, a lack of amplification when using PCR to verify the quality of the library prior to 
sequencing (Steps 80-83). A ‘positive’ control experiment that allows the specificity of generated 
libraries to be estimated can be achieved through substitution of the endonuclease for one with 
well-defined sequence specificity. We originally performed such controls30 using BciVI (New England 
Biolabs), which cleaves both strands, and the nicking endonuclease Nb.BtsI (New England Biolabs). 
The preparation of control libraries using sequence specific endonucleases provides the additional 
advantage of enabling the bioinformatic processing of sequence data to be optimised using a library 
with highly predictable results. It should, however, be noted that due to the sensitivity of the 
EndoSeq method even low levels of star activity can be observed. 
MATERIALS 
Reagents 
For gDNA isolation from S. cerevisiae: 
 RNase H2 deficient S. cerevisiae, such as SNM106 (a kind gift from T. Kunkel) or its 
derivatives6,30 (5 A600 nm unit pellets can be stored at -80°C). 
 Glass beads, Ø 0.4-0.6 mm (Sartorius, cat. no. BBI-8541701) 
 10% (vol/vol) Triton X-100 (Sigma, cat. no. T8787) CAUTION Triton X-100 is corrosive. Wear 
personal protective equipment. 
 20% (wt/vol) Sodium dodecyl sulfate (SDS, Sigma, cat. no. 05030) CAUTION SDS is corrosive 
and toxic. Wear personal protective equipment and avoid inhalation. 
 Sodium Chloride (NaCl, Sigma, cat. no. S3014) 
 Tris(hydroxymethyl)methylamine (Tris base, Sigma, cat. no. T4661) 
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 Boric acid (Sigma, cat. no. B7901) 
 Ethylenediaminetetraacetic acid (EDTA, Sigma, cat. no. E6758) 
 Phenol pH 7.9 (Sigma, cat. no. P4557) CAUTION Phenol is corrosive and toxic. Wear personal 
protective equipment and handle it in a fume hood. 
 Phenol:chloroform:isoamylalcohol (25:24:1) (Sigma, cat. no. P3803) CAUTION 
Phenol:chloroform:isoamylalcohol is corrosive and toxic. Wear personal protective 
equipment and handle it in a fume hood. 
 Chloroform (Sigma, cat. no. C2432) CAUTION Chloroform is toxic. Wear personal protective 
equipment and handle it in a fume hood. 
 100% Ethanol (EtOH, Sigma, cat. no. E7023) CAUTION Ethanol is highly flammable. Handle 
away from potential sources of ignition. 
 Nuclease free distilled water (H2O, Life-Technologies, cat. no. 10977) 
 RNase, DNAse-free (Roche, cat. no. 11 119 915 001) 
 Poly(ethylene glycol) 8000 (PEG8,000, Sigma, cat. no. 89510) 
 Agencourt Ampure XP beads (Beckman Coulter, cat. No. A63880)  
For library preparation from gDNA 
 Agarose (electrophoresis grade, Sigma, cat. no. A9539) 
 SYBR® Gold nucleic acid stain, 10,000x in DMSO (Life Technologies, cat. No. S-11494) 
 100 bp DNA ladder (e.g. Promega, cat. no. G210A, supplied with Blue/Orange 6X Loading 
Dye) 
 NEBNext® end repair module (New England Biolabs, cat. no. E6050) 
 NEBNext® dA-tailing module (New England Biolabs, cat. no. E6053) 
 NEBNext® Quick Ligation module (New England Biolabs, cat. no. E6056) 
 Custom oligonucleotides; ours were synthesised by Eurogentec and purified using 
manufacturer recommended methods (Table 1). 
 Terminal Transferase, supplied with 10x reaction buffer and 2.5 mM CoCl2 (New England 
Biolabs, cat. no. M0315) 
 10 mM ddATP, Sequencing Grade Na-salt pH 8.3 (Roche, cat. no. 03 732 738 001) 
 RNase HII (New England Biolabs, cat. no. M0288) or recombinant human RNase H2 (purified 
as previously described46) for emRiboSeq; other recombinant (nicking) endonuclease of 
interest for EndoSeq. CRITICAL: alternative sources of recombinant type 2 RNase H enzymes 
may be used 
 10% (wt/vol) Bovine Serum Albumin Fraction V (BSA, Roche, cat. no. 10 735 086 001) 
 Magnesium chloride (MgCl2, Sigma, cat. no. M2670) 
 Nb.BtsI, Supplied with 10x CutSmart® buffer (New England Biolabs, cat. no. R0707) 
 BciVI, Supplied with 10x CutSmart® buffer (New England Biolabs, cat. no. R0596) 
 Shrimp Alkaline Phosphatase (SAP), supplied with 10x reaction buffer (Affymetrix USB®, cat. 
no. 70092Z) 
 Dynabeads® M-280 Streptavidin (Life Technologies, cat. no. 11205D) 
 Tri-sodium citrate (Sigma, cat. no. C8532) 
 Glycogen (Roche, cat. no. 10 901 393 001) 
 Sodium acetate (NaOAc, Sigma, cat. no. S2889) 
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 Sodium hydroxide (NaOH, Sigma, cat. no. 38215) CAUTION Sodium hydroxide is corrosive. 
Wear personal protective equipment. 
 Phusion Flash High-Fidelity PCR Master Mix (Thermo Scientific, cat. no. F-548) 
 E-Gel® SizeSelect™ Agarose Gels, 2% (Life Technologies, cat. no. G6610-02) 
 Agilent High Sensitivity DNA Kit (Agilent Technologies, cat. no. 5067-4626) 
 Potassium Chloride (KCl, Sigma, cat. no. P9541) 
 Ion 318™ Chip Kit v2 (Life Technologies, cat. no. 4484534) or Ion PI™ Chip Kit v2 (Life 
Technologies, cat. no.  4482413) 
 Ion PGM™ Template OT2 200 Kit (Life Technologies, cat. no. 4480974) or Ion PI™ Template 
OT2 200 Kit v2 (Life Technologies, cat. no. 4485146) 
 Ion PGM™ Sequencing 200 Kit v2 (Life Technologies, cat. no. 4482006) or Ion PI™ sequencing 
kit (Life Technologies, cat. no. 4485149). CRITICAL: These Ion Torrent sequencing products 
are under constant development. We therefore suggest using the most appropriate 
equivalent recommended products. 
Equipment 
 Nuclease-free 1.5 ml tubes (Starlab, cat. no. E1415-1500) 
 Vortex MS 3 basic (IKA, cat. no. 0003617000) 
 Table-top centrifuge (Eppendorf, cat. no. 5424 R) 
 Agarose gel electrophoresis equipment 
 DynaMag™-2 Magnet, magnetic stand (Life Technologies, cat. no. 12321D) 
 Nanodrop spectrophotometer (Thermo Scientific) 
 Bioruptor® Plus with 1.5 ml tube holder (Diagenode, cat. no. B01020001) 
 Rotator (IKA, cat. no. 0004015000) 
 Thermocycler (Biorad, cat. no. C1000) 
 E-Gel® iBase™ Power System (Life Technologies, cat. no. G6400) 
 2100 Electrophoresis Bioanalyzer Instrument (Agilent Technologies, cat. no. G2939AA) 
 Ion OneTouch™ 2 System (Life Technologies, cat. no. 4474779) 
 Ion PGM™ Sequencer (Life Technologies, cat. no. 4462921) or Ion Proton™ Sequencer (Life 
Technologies, cat. no. 4476610) 
Reagent Setup 
Solutions 
CRITICAL: Prepare all of the following solutions using nuclease-free water. 
 Lysis buffer (2% Triton X-100, 1% SDS, 0.5 M NaCl, 10 mM Tris, 1 mM EDTA, pH8.0; store at 
room temperature (RT) for up to six months) 
 TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0; store at RT for up to six months) 
 0.5x TBE (44.5 mM Tris, 44.5 mM Boric acid, 1 mM EDTA, pH 8.0; store at RT for up to six 
months) 
 0.5 M NaCl (store at RT for up to six months) 
 75% (vol/vol) EtOH (store at RT for up to six months) 
 3 M NaOAc pH 5.2 (store at RT for up to six months) 
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 40% (wt/vol) PEG8,000, 1.25 M NaCl (filter sterilise using a 0.22 µm filter and store at 4°C for 
up to six months; warm to RT before use) 
 5x Oligonucleotide annealing buffer (300 mM KCl, 250 mM Tris, pH 8.0; store at RT for up to 
six months) 
 2x RNase H2 reaction buffer for use with recombinant human RNase H246 (120 mM KCl, 100 
mM Tris-HCl pH 8.0, 20 mM MgCl2, 0.02% BSA, 0.02% Triton X-100; store at 4°C for up to six 
months) 
 0.15 M NaOH (make up fresh) 
 Saline sodium citrate (SSC) (0.15 M NaCl, 0.015 M sodium citrate, pH 7.0; store at RT for up 
to six months)  
 1x Bind and Wash buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 2 M NaCl; store at RT for up to 
six months) 
 2x Bind and Wash buffer (20 mM Tris-HCl pH 7.5, 2 mM EDTA, 4 M NaCl; store at RT for up to 
six months) 
Double stranded adapters 
Prepare the first adapter (dstrP1) by combining oligonucleotides trP1-top and trP1-bottom, and the 
second adapter (dsA) by combining A-top and A-bottom (see Table 1 for oligonucleotide sequences). 
In each case, prepare 100 µl 40 µM double stranded adapter as follows: Combine 40 µl of each single 
stranded oligonucleotide (100 µM) with 20 µl 5x oligonucleotide buffer, incubate at 95°C for 5 min in 
a thermocycler, before removing and allowing to cool gradually to RT (store at -80°C for up to one 
year). 
 
Table 1: Oligonucleotides used in library preparation and quality control. All sequences 
are given 5’ to 3’. 
Oligonucleotide Sequence 
trP1-top CCTCTCTATGGGCAGTCGGTGAT-phosphorothioate-T 
trP1-bottom phosphate-ATCACCGACTGCCCATAGAGAGG-dideoxyC 
A-top phosphate-CTGAGTCGGAGACACGCAGGGATGAGATG-dideoxyG 
A-bottom biotin-CCATCTCATCCCTGCGTGTCTCCGACTCAGNNNNNN-C3-phosphoramidite 
primer A CCATCTCATCCCTGCGTGTCTCCGAC 
primer trP1 CCTCTCTATGGGCAGTCGGTGATT 
 
PROCEDURE 
gDNA isolation from yeast TIMING 2-3 h 
1 Add 200 μl of lysis buffer and ~0.2 ml of glass beads to the pellet from a yeast culture (5 A600 nm 
units), in a 1.5 ml tube. To isolate sufficient gDNA for a particular sample, we usually carry out 
Steps 1-14 with 8 tubes per sample (i.e. a total of 40 A600 nm units). These can be pooled in Step 
14, and subsequent steps carried out for multiple samples at once, making appropriate 
adjustments for the larger volume. Amounts given in Steps 1-23 are for a single tube containing 
5 A600 nm units. 
Page 10 of 21 
 
2 Add 200 μl of phenol and vortex for 2 min (continuous mixing at 3,000 rpm). 
3 Add 200 μl of TE and vortex for 1 min (continuous mixing at 3,000 rpm). 
4 Centrifuge at 5,000 g for 5 min, 4°C. 
5 Transfer the aqueous phase to a new 1.5 ml tube, add 400 μl of 
phenol:chloroform:isoamylalcohol (25:24:1) and vortex for 30 s. 
6 Centrifuge for 5 min at 5,000 g, 4°C. 
7 Add 400 μl of chloroform and vortex for 30 s. 
8 Centrifuge at 5,000 g for 2 min, 4°C. 
9 Transfer the aqueous phase to a new 1.5 ml tube, add 1 ml of ice-cold 100% EtOH and mix 
thoroughly by repeated inversion.  
10 Centrifuge at ≥ 13,000 g for 10 min, 4°C and remove the supernatant. 
11 Wash the pellet with 0.5 ml 75% EtOH. 
12 Centrifuge at ≥ 13,000 g for 2 min, 4°C and remove the supernatant. 
13 Air-dry the pellet at RT. 
14 Resuspend the pellet containing total nucleic acids in 50 µl of 0.5 M NaCl. CRITICAL STEP: 
Replicates can be pooled at this stage (making appropriate adjustments for the larger volume in 
subsequent steps). 
15 Add 1 µl of DNase-free RNase (0.5 µg/µl) and incubate for 1 h at RT. 
DNA purification 
16 Add 50 µl of Ampure XP after allowing it to equilibrate to RT for at least 5 min (1x volume). 
17 Mix thoroughly and incubate for >1 min at RT. If necessary centrifuge briefly (1,500 g for 1 s at 
RT) to collect droplets. 
18 Place on a magnetic stand for >1 min. The beads will collect near the magnet and the solution 
will become clear. Remove and discard the supernatant.  
19 Without removing the tube from the stand, wash twice with 500 µl 75% EtOH. Mixing can be 
achieved by rotating the tube on the stand. Remove and discard the supernatant. 
20 Ensure the beads are dry before resuspending in the required volume and diluent as detailed in 
the next step. This can take a few min at RT. 
21 Elute DNA in 50 µl H2O, by vortexing to resuspend and incubating at RT for 1 min. 
22 Using the magnetic stand to retain the beads, transfer the eluate to a new 1.5 ml tube and 
discard the beads. 
23 Measure the concentration of eluted gDNA using 1.5 µl on a nanodrop spectrophotometer. 
Usually ~3 µg of DNA can be expected per 5 A600 nm units of culture. CRITICAL STEP: If visualised 
on an agarose gel an additional band, which migrates at around 4.5 kb, is present. This appears 
to be RNA resistant to RNase cleavage at 0.5 M NaCl, but sensitive to subsequent degradation by 
RNase A at low salt concentration. 
PAUSE POINT 
gDNA can be stored at -80°C for at least 7 d (storage at -80°C is recommended to prevent any 
unwanted RNase activity on embedded ribonucleotides). 
Sonication TIMING 2-3 h 
24 Prepare 300 µl aliquots of 10 ng/µl DNA in H2O in 1.5 ml tubes. Ideally, 6 aliquots (18 µg) of DNA 
should be sonicated per library, however using as few as 3 aliquots can give enough material to 
proceed.  
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25 Sonicate each aliquot to achieve an average length of ~400 bp using a Bioruptor® Plus, following 
the manufacturer’s recommendations. 
26 Confirm the distribution of fragments by gel electrophoresis: Load 10 µl per aliquot alongside 
100 bp DNA ladder on a 0.5x TBE, 1% agarose gel. Electrophorese and visualise using a nucleic 
acid stain (e.g. SYBR® Gold). CRITICAL STEP The distribution of fragment sizes will have a strong 
influence on the concentration of the library following size selection. In our experience, an 
average length of ~400 bp can be achieved with 18 cycles of 30 s sonication and 60 s cooling on 
the ‘high’ setting, however this is likely to require optimisation in each lab. Once the desired 
distribution of fragments is achieved, ethanol precipitate the DNA. Assuming 290 µl per tube, 
add 1 µl glycogen, 29 µl 3M NaOAc and 800 µl 100% EtOH.  
27 Precipitate for 1 h at -20°C and centrifuge at ≥ 13,000 g for 30 min, 4°C and remove the 
supernatant. 
28 Wash the pellet with 0.5 ml 75% EtOH. 
29 Centrifuge at ≥ 13,000 g for 2 min, 4°C and remove all supernatant. 
30 Air dry pellet, dissolve and pool pellets from all aliquots of each library in a total volume of 100 
µl H2O. 
31 Purify DNA by repeating Steps 17-23, using 120 µl Ampure XP (1.2x volume) and eluting in 86.5 
µl H2O. 
CRITICAL STEP The large amount of small fragments generated during sonication can lead to a 
loss of up to 70% of the initial DNA. Whilst we have prepared libraries using as little as 1 μg, we 
recommend taking through 5 μg of sonicated DNA to the next steps. Subsequent steps, including 
reaction and purification conditions, as well as elution volumes, assume 5 μg of sonicated DNA is 
used and should be scaled accordingly if this is not the case. 
PAUSE POINT 
Sonicated DNA can be stored at -80°C for at least 7 d. 
End repair, dA-tailing and adapter ligation TIMING ~3 h + overnight 
incubation 
32 To 5 µg of sonicated DNA in 85 µl H2O add 10 µl 10x buffer and 5 µl enzyme mix from the 
NEBNext® end repair module. 
33 Incubate for 1 h at 20°C. 
 
34 Purify DNA by repeating Steps 17-21, using 120 µl Ampure XP (1.2x volume) and eluting in 42 µl 
H2O. 
CRITICAL STEP: Do not separate from the beads as they can be reused and do not interfere with 
the dA-tailing reaction. 
35 Add 5 µl 10x buffer and 3 µl Klenow Fragment (3´→ 5´ exo–) from the NEBNext® dA-tailing 
module. 
36 Incubate for 1 h at 37°C. 
37 Add 17 µl 5 M NaCl and 22.5 µl 40% PEG8,000, 1.25 M NaCl. 
38 Purify DNA by repeating Steps 17-21, eluting in 20 µl H2O. 
CRITICAL STEP: Do not separate from the beads as they can be reused and do not interfere with 
adapter ligation. 
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39 Add 10 µl 5x buffer, 15 µl 40 µM dstrP1 adapter and 5 µl T4 Quick Ligase from the NEBNext® 
quick ligation module. 
40 Incubate overnight or for at least 12 h at 16°C. Ligation for shorter times may be possible, but we 
have not tested this. 
41 Add 17 µl 5 M NaCl and 22.5 µl 40% PEG8,000, 1.25 M NaCl. CRITICAL STEP: 1x NEBNext Ligation 
buffer contains 6% PEG6,000 and may therefore alter the size selection effect, however this 
nucleation procedure has proved sufficient to significantly deplete the adaptors. 
42 Purify DNA by repeating Steps 17-22, eluting in 195 µl H2O. 
3’ blocking and endonucleolytic treatment TIMING ~4.5 h 
43 Add 25 µl 10x Terminal Transferase reaction buffer, 25 µl 2.5 mM CoCl2, 2.5 µl 10 mM ddATP, 2.5 
µl 20 U/µl Terminal Transferase. 
44 Incubate at 37°C for 2 h. 
 
45 Purify DNA by repeating Steps 17-23, using 300 µl Ampure XP (1.2x volume) and eluting the 3’ 
blocked DNA in 51.5 µl H2O. 
 
Use the obtained concentration to scale subsequent reactions. Normally 2-3 μg of DNA remains 
at this point. CRITICAL STEP Subsequent steps, including reaction and purification conditions, as 
well as elution volumes, assume 2 μg of DNA is used and should be scaled accordingly if this 
deviates significantly. 
46 Endonuclease treatment: This should be optimised for each new endonuclease. The following 
reaction conditions were successfully employed for Escherichia coli RNase HII (option A), human 
RNase H2 (option B; note that alternative sources of type 2 RNase H enzymes may be used) and 
Nb.BtsI (option C).  
A RNase HII treatment  
i To 2 μg of 3’ blocked DNA in 50 µl add 10 µl 10x reaction buffer (provided), 50 U 
RNase HII and H2O up to 100 µl. 
ii Incubate for 2 h at 37°C and then inactivate by incubating for 20 min at 80°C. 
B RNase H2 treatment 
i To 2 μg of 3’ blocked DNA in 50 µl add 50 µl 2x RNase H2 reaction buffer and 20 
pmol RNase H2. CRITICAL STEP: This large excess of enzyme was used to ensure 
complete digestion, but lower amounts are likely sufficient.  
ii Incubate for 2 h at 37°C and then inactivate by incubating for 20 min at 80°C. 
C Nb.BtsI treatment 
i To 2 μg of 3’ blocked DNA in 50 µl add 10 µl 10x CutSmart® buffer, 0.5 µl 10 U/µl 
Nb.BtsI and 39.5 µl H2O. 
ii Incubate for 1 h at 37°C and then inactivate by incubating for 20 min at 80°C. 
CRITICAL STEP: This enzyme exhibits star activity, particularly when high 
concentrations of enzyme or long incubation times are used. 
PAUSE POINT 
Endonuclease treated samples can be stored at -20°C for at least 7 d. 
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Dephosphorylation and second adapter ligation TIMING 2 h + overnight 
incubation 
 
47 Purify DNA by repeating Steps 17-21, using 120 µl Ampure XP (1.2x volume) and eluting in 85 µl 
H2O. 
CRITICAL STEP: Do not separate from the beads as they can be reused and do not interfere with 
the de-phosphorylation reaction. 
48 Add 10 µl 10x SAP reaction buffer and 5 µl 1 U/µl SAP. 
49 Incubate at 37°C for 1 h and then inactivate by incubating for 15 min at 65°C. 
50 Add 34 µl 5 M NaCl and 45 µl 40% PEG8,000, 1.25 M NaCl. 
51 Purify DNA by repeating Steps 17-22, eluting in 29 µl H2O. 
52 Incubate the library at 95°C for 5 min in a thermocycler and then snap cool in an icy water bath. 
CRITICAL STEP Libraries must be denatured immediately prior to ligation.  
53 Once cooled, immediately add 10 µl 5x buffer, 6 µl 40 µM dsA adapter and 5 µl T4 Quick Ligase 
from the NEBNext® quick ligation module. 
54 Incubate overnight or for at least 12 h at 16°C. CRITICAL STEP: Ligation for shorter times may be 
possible, but we have not tested this. 
55 Purify DNA by repeating Steps 17-22, using 90 µl Ampure XP (1.8x volume) and eluting in 40 µl 
H2O. 
PAUSE POINT 
Eluted DNA fragments can be stored at -20°C for at least 7 d. 
Single stranded library preparation, second strand synthesis and size 
selection TIMING 4-5 h 
56 Resuspend Dynabeads® M-280 Streptavidin and transfer 20 µl to a new 1.5 ml tube. 
57 Using a magnetic stand to retain the beads, discard the supernatant and replace with 1 ml 1x 
Bind and Wash buffer. 
58 Using a magnetic stand to retain the beads, discard the supernatant and replace with 40 µl 2x 
Bind and Wash buffer. 
59 Add the whole 40 µl of adapter-ligated library from Step 55 and incubate at RT for 15 min on a 
rotator. 
60 Using a magnetic stand to retain the beads, discard the supernatant and replace with 50 µl SSC. 
61 Incubate at RT for 5 min on a rotator. 
62 Repeat Steps 60-61 to ensure no unbound fragments are carried through. 
63 Using a magnetic stand to retain the beads, discard the supernatant and replace with 40 µl 0.15 
M NaOH. 
64 Incubate at RT for 10 min on a rotator. 
65 Using a magnetic stand to retain the beads, transfer the eluate to a new 1.5 ml tube. 
66 Repeat the elution: add 40 µl 0.15 M NaOH to the beads from Step 65, incubate at RT for 5 min 
on a rotator, use a magnetic stand to retain the beads and pool the eluate from this step with 
that collected in Step 65. 
67 Add 120 µl H2O to the pooled eluate and ethanol precipitate by adding 1 µl glycogen, 20 µl 3 M 
NaOAc and 550 µl 100% EtOH. 
68 Precipitate and wash the DNA by repeating Steps 27-30. 
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69 Dissolve the pellet containing the single stranded library in 9.5 µl H2O. 
70 Add 0.5 µl 10 µM primer A and 10 µl 2x Phusion Flash Master mix. 
71 In a thermocycler, incubate the 20 µl reaction at 98°C for 1 min, followed by 58°C for 30 seconds, 
and 72°C for 1 min. 
72 Purify DNA by repeating Steps 17-22, using 36 µl of Ampure XP (1.8x volume) and eluting in 20 µl 
H2O. 
73 Set up a 2% E-Gel® SizeSelect™ agarose gel on the iBase™ Power System according to 
manufacturer’s instructions. 
74 Load the library directly into the desired well; loading dye is unnecessary. Use 100 bp DNA 
ladder as a marker. 
75 Once the 200 bp fragment has entered the collection well start collecting the library. Pause the 
electrophoresis every five seconds, mix and remove the liquid in the collection well, transferring 
it to a 1.5 ml collection tube, then replenish the well (20 µl H2O). Stop once the 300 bp fragment 
has completely entered the collection well. A total of ~500 µl is usually collected per sample. 
Alternatively, the sample can be separated by conventional agarose gel electrophoresis and 
fragments between 200 and 300 bp purified by gel extraction, e.g. we have successfully applied 
the QIAquick Gel Extraction Kit (QIAGEN, cat.no. 28704) following the manufacturer’s 
instructions (if this alternative is used, proceed to Step 78). 
76 Assuming 500 µl has been collected, divide size-selected DNA into 2 x 250 µl in 1.5 ml tubes and 
ethanol precipitate by adding 25 µl of 3 M NaOAc and 700 µl 100% EtOH. 
77 Precipitate and wash by repeating Steps 27-30. 
78 Dissolve each pellet in 20 µl H2O and purify by repeating Steps 17-22, using 36 µl Ampure XP 
(1.8x volume) and eluting in 15 µl H2O. 
CRITICAL STEP Contaminants, such as carried over Ampure beads, can disrupt library 
quantification using the Bioanalyzer. 
PAUSE POINT 
Prepared libraries can be stored at -20 °C overnight, or if necessary, for up to 7 d. 
Library quality control and sequencing 
79 Transfer 0.5 μl to a new tube for further library verification by PCR. Dilute this aliquot 1 in 20, by 
adding 9.5 μl H2O. 
80 Set up three PCR reactions per library, each using 0.5 μl of the 1 in 20 library dilution, 0.5 μl 10 
μM primer trP1, 0.5 μl 10 μM primer A, 8.5 μl H2O and 10 μl 2x Phusion Flash master mix.  
81 Using a thermocycler incubate the reactions at 98°C for 10 sec, followed by 15 cycles for one 
reaction, 16 for the second and 17 for the third, with each cycle 1 s at 98°C,  5 s at 58 oC and 5 s 
at 72°C; finally, incubate at 72°C for 1 min. ?Troubleshooting 
82 Load 10 µl of each reaction alongside 100 bp DNA ladder on a 0.5x TBE, 1% agarose gel. 
Electrophorese and visualise using a nucleic acid stain, allowing a qualitative as well as semi-
quantitative assessment: Successfully generated libraries yield a smear between ~200 and 300 
bp that is usually visible after 15 cycles of amplification. 
83 Following the manufacturer’s protocol, confirm the size distribution of the library and estimate 
its concentration using a Bioanalyzer and High Sensitivity DNA Kit (Agilent). ?Troubleshooting 
84 Assuming the Bioanalyzer trace shows a quantifiable distribution of material between ~200 and 
300 bp, which is confirmed by PCR, the library can then be prepared for Ion PGM™ or Ion 
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Proton™ sequencing following the manufacturer’s protocol. CRITICAL STEP: The Bioanalyzer 
trace and PCR amplification from a typical library are shown in Fig. 2b and c. The required input 
for Ion OneTouch™ emulsion PCR is 100 μl of 12 pM for the Ion Proton™ and 26 μl of 25 pM for 
the Ion PGM™.  We recommend using the Ion PI™ Chip to achieve the maximum number of 
reads. Alternatively the Ion 318™ Chip can be used. 
Bioinformatics 
85 Align sequence reads to the appropriate genome (we use sacCer3) with bowtie2 (we used 
version 2.0.0). Command:  
  bowtie2 -x sacCer3 -U runName.fastq runName.sam 
86 Perform alignment quality filtering and format conversion using Samtools (we used version 
0.1.18) and BEDTools (we used version 2.16.2). A Bam file (denoted runName.master.bam 
below) containing all mapped and unmapped reads is a convenient way to store the complete 
raw sequence and quality information, as well as the alignment to the reference genome. 
Samtools view with the –q 30 option only retains reads with a mapping quality score >30 
(misalignment probability < 0.001) for analysis. The ribonucleotide incorporation site is one 
nucleotide upstream and on the opposite strand to the mapped read 5' end, a transformation 
that can be achieved with the short Perl code illustrated below. All command syntaxes shown 
assume a Bash shell and standard Unix tools in addition to the specific software mentioned 
above. Commands:  
samtools view -b -S runName.sam > runName.master.bam 
samtools view -b -q 30 -S runName.sam > runName.bam 
bamToBed -i runName.bam > runName.bed 
   perl -alne \\ 
'if($F[5]=~s/\+/-/){$F[2]=$F[1];$F[1]--;} \\ 
else{$F[5]=~s/-/\+/;$F[1]=$F[2];$F[2]++} \\ 
print join "\t", @F' \\ 
< runName.bed | sort –k1,1 –k2,2n –k 6 > runName.ribo.bed 
87 To facilitate comparison between libraries of differing read depth, normalise read counts to 
sequence tags per million (TPM =(fpe/total_fpe)*1x106 ,where fpe is 5’ end reads at site and 
total_fpe is total number genome mapped 5’ ends). Conversion to ribonucleotide counts per site 
(and strand) and the TPM normalisation can be achieved with the following commands:  
bedtools groupby -i runName.ribo.bed -g 1,3,6 -c 1 -full \\ 
-o count > runName.counts.bed 
export totalfpe=`wc -l runName.ribo.bed | awk '{print $1}'` 
cat runName.counts.bed | perl -alne \\  
'$F[6]=($F[6]/$ENV{totalfpe})*1e6; print join "\t", @F;' \\ 
> runName.tmp.bed 
88 Subsequent analysis can be performed in the R statistical environment (or Excel) by importing 
the tab delimited Bed file runName.tmp.bed. Such files can also be loaded into common genome 
browsers for visualisation and provided as “processed data files” to the Gene Expression 
Omnibus (GEO) and similar repositories along with the raw data (fastq file). CRITICAL STEP: 
Automation of emRiboSeq sequence processing (Steps 85-87) can be achieved using the script 
found at https://github.com/taylorLab/LaggingStrand/blob/master/emRiboSeqProcessor.sh with 
further details available in ref. 30 and examples of code performing analysis at 
https://github.com/taylorLab/LaggingStrand/  
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TIMING 
Day 1 
 Steps 1-23, gDNA isolation from yeast: 2-3 h. 
Day 2 
 Steps 24-31, sonication: 2-3 h. 
 Steps 32-40, end repair, dA-tailing and adapter ligation: ~3 h + overnight incubation. 
Day 3 
 Steps 41-46, 3’ blocking and endonucleolytic treatment: ~4.5 h. 
 Steps 47-54, dephosphorylation and second adapter ligation: ~2 h + overnight incubation. 
Day 4 
 Steps 55-78, single stranded library preparation, second strand synthesis and size selection: 
4-5 h.  
 Steps 79-84, library quality control (~2h). 
Day 5 
 Steps 85-88, sequencing followed by bioinformatics processing of data (several days). 
Several potential pause points have been highlighted within the protocol. If necessary, it is also 
possible to pause at many other points. However, it should be noted that Ampure XP beads should 
be removed prior to freezing and reintroduced before the next purification step. 
TROUBLESHOOTING 
 
Step Problem Possible reason Possible solution 
81 Amplification of 
‘endonuclease 
negative’ control 
library 
Incomplete 
removal of 3’-OH 
groups 
Ensure that the 3’ blocking reaction conditions and 
timing are optimal for the terminal transferase used 
(Steps 43-44). 
83 Poor bioanalyzer 
trace 
Carry over of 
Ampure beads or 
other contaminant 
Additional purification (a further round of Ampure 
Bead purification or spin column based purification) 
may help, but is not guaranteed to improve the 
trace. N.B. we have successfully generated high 
quality sequencing data from samples that failed to 
produce good Bioanalyzer traces. In these cases we 
estimated the concentration based on the semi-
quantitative PCR performed in Step 81, and 
comparing it with results from a previous library.  
 
ANTICIPATED RESULTS 
EmRiboSeq libraries generated using this protocol typically had a concentration of 400-2,000 pM. 
The total number of reads for the Ion 318™ Chip was typically 4-6 million, and an order of magnitude 
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higher for the Ion PI™ Chip at 50-90 million reads. Of these reads 70-80% mapped unambiguously 
(phred scaled mapping quality >30) to the yeast genome, resulting in an average read coverage of 
>35-fold for the Ion 318™ Chip and >400-fold for the PI™ Chip, with 150 base reads. However, for 
embedded ribonucleotide mapping it is the read 5’ end coverage over the genome rather than 
sequenced read coverage that matters. For this measure, 0.2x to 0.4x genome average coverage for 
the Ion 318™ Chip and 3x to 6x coverage with the PI™ Chip was typical.  Results for libraries 
prepared using other endonucleases are likely to be similar, as was the case for control libraries 
prepared using sequence specific endonucleases. Independent libraries yielded highly reproducible 
data, and demonstrated >99.9% site and strand specificity and >99% single nucleotide resolution 
(Fig. 2c and d). 
 
It was previously unknown if embedded ribonucleotides were randomly distributed throughout the 
genome. The advent of a number of high-throughput sequencing methods, including emRiboSeq, 
has started to shed light on this. It is now clear that this distribution is non-random, with certain 
patterns emerging, including those related to polymerase-dependent nucleotide preferences, as well 
as sequence context30,33-35. The way is now open to investigate genome-wide ribonucleotide 
incorporation, uncover which rules underlie the observed distribution and determine the 
(patho)physiological consequences. 
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Figure 1 | The emRiboSeq protocol. Schematic depicting processing of ribonucleotide (red ‘R’) and 
non-ribonucleotide containing DNA fragments. The first adapter (blue) attaches to both fragments, 
but only those that contain ribonucleotides will be captured for sequencing after ligation with the 
second adapter (pink). For EndoSeq, a different endonuclease is used in place of RNase H2 (Step 46). 
OH, hydroxyl; P, phosphate; A, deoxyadenosine; T, deoxythymidine; dd, dideoxynucleoside; Bio, 
biotinylated nucleoside; NNNNNN, random deoxynucleotide hexamer. Adapted from ref. 30. 
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Figure 2 | Library quality control and anticipated results. (a) Sonicated DNA separated by agarose gel 
electrophoresis (Step 26) shows an average fragment size of approximately 400 bp. (b) Bioanalyzer 
result (Step 83) for an emRiboSeq library shows a typical trace (left) and gel-like image (right) with a 
peak for fragments between ~180 and ~300 bp in size (black bar). Standards (green and purple bars) 
of defined size and amount allow quantification. FU, arbitrary fluorescence units. (c) Agarose gel 
electrophoresis of PCR products after 15, 16 and 17 cycles of amplification (Steps 80-82) of the same 
library shows product between 200 and 300 bp in size. (d) Sequencing results for libraries generated 
using Nb.BtsI are highly reproducibility between different strains (POL, wildtype polymerase; pol1-
L868M, increased Pol-α ribonucleotide incorporation) after normalizing read counts to sequence 
tags per million (TPM).  The majority of bona fide Nb.BtsI sites were present at maximal frequency, 
although some sites were present at lower frequencies. This is the result of partial loss during size 
selection because of their close proximity to other cleavage sites, a highly reproducible finding 
between independent libraries (Spearman's rho=0.82, p <2.2-e16). Due to star activity Nb.BtsI-like 
sites were also detected. Other libraries prepared using BciVI restriction enzyme digestion did not 
show such star activity (data not shown), and allowed calculation of the site specificity for the 
method (>99.9%). (e) Summed signal at Nb.BtsI sites (dark blue, correct strand; light blue, opposite 
strand) highlights the strand specificity (>99.9%) and single nucleotide resolution (>99%) of this 
method. Panels d and e adapted from ref. 30. 
 
 
